Carotid ultrasound to predict blood pressure drops during dialysis
Official title: The Predictive Value of Carotid Corrected Flow Time and Peak Flow Velocity Variability for Intradialytic Hypotension: A Prospective Multicenter Observational Study
Run by First Affiliated Hospital of Wannan Medical College · NCT07033260 · Data updated 2026-11-12
We're testing whether carotid ultrasound measurements can help predict which adults on long-term hemodialysis will have drops in blood pressure during treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 183 (estimated) |
| Sponsor | First Affiliated Hospital of Wannan Medical College Academic / other |
| Locations | 1 site (Wuhu, Outside of the US) |
| Status | Recruiting |
| Started | February 1, 2025 |
| Main results expected | August 30, 2025 |
| Study ends | August 30, 2025 |
| Registry record updated | June 24, 2025 |
| Trial ID | NCT07033260 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 with end-stage renal disease who have been on maintenance hemodialysis for at least three months and can undergo carotid ultrasound and give informed consent.
✕Probably not a fit
Patients with significant carotid stenosis, unstable cardiovascular status, major arrhythmias, inability to receive ultrasound, or those taking antihypertensive medications during dialysis are unlikely to benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter prospective observational study will enroll adults with end-stage renal disease receiving maintenance hemodialysis to measure carotid corrected flow time (FTc) and peak flow velocity variability (PFVV). Ultrasound assessments will be performed once at about one hour after dialysis initiation while blood pressure is continuously monitored during the session. The primary analysis will determine the sensitivity, specificity, and optimal cutoff points of FTc and PFVV for predicting intradialytic hypotension. Patients with major carotid stenosis, significant arrhythmias, hemodynamic instability, or inability to undergo ultrasound are excluded.
Why it matters
Potential benefit: If successful, this could allow clinicians to identify patients at high risk for intradialytic hypotension and take preventive steps during dialysis.
How similar studies have gone: Small prior studies and physiologic data support a link between carotid flow measures and volume or hemodynamic status, but large multicenter validations are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Adults aged 18 to 80 years. Diagnosed with end-stage renal disease (ESRD). Undergoing maintenance hemodialysis for more than three months. Willing and able to provide informed consent and comply with study procedures. Exclusion Criteria: Patients with significant carotid artery stenosis due to heavy atherosclerotic plaque (defined as more than 70% stenosis confirmed by ultrasound or angiography). Hemodynamically unstable patients or those requiring vasopressor support. Patients with significant arrhythmias (e.g., atrial fibrillation, ventricular tachycardia). Dialysis sessions terminated for reasons unrelated to hypotension (e.g., technical issues, patient request). Use of antihypertensive medications during dialysis sessions. Inability to undergo ultrasound assessment due to factors such as severe obesity or wounds obstructing access. Patients who withdraw informed consent during the study.
Where it's running
-
The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)
Wuhu, Outside of the US, China Recruiting
Study contacts
- Study coordinator: Qiancheng Xu
- Email: qianchengxu@wnmc.edu.cn
- Phone: 86-18297529106
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pleth Variability Index to predict low blood pressure during maintenance hemodialysis
This will test whether a simple pulse-oximeter reading (PVI) can help predict which adults on routine hemodialysis will develop low blood pressure so clinicians can act earlier.
-
Hemoadsorption with the Jafron HA130 cartridge during hemodialysis for adults on maintenance dialysis with inflammation
This trial will try adding Jafron HA130 hemoadsorption to regular hemodialysis to see if it reduces inflammation in adults on maintenance dialysis who have high CRP or IL-6.
-
Using IVC collapsibility and diameters to predict blood pressure drops during hemodialysis
This project tries to see whether measuring the inferior vena cava collapsibility index and diameters one hour into dialysis can predict blood pressure drops in adults on maintenance hemodialysis.
-
Bioimpedance Spectroscopy for Fluid Changes in Hemodialysis Patients
This study tests whether raw bioimpedance data can help doctors gauge fluid changes in people on hemodialysis and guides fluid removal decisions.
-
Nurse-led dialysis self-management program for distress in adults on hemodialysis
A nurse-led program helps adults on hemodialysis see if structured self-management support reduces dialysis-related distress compared to routine care.
-
Repeated brief limb ischemia to see its effect on blood pressure and inflammation in people with kidney disease
This study tests whether short, repeated episodes of limb ischemia can influence blood pressure, heart rate, and inflammation in adults with chronic kidney disease who may be on hemodialysis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.